Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-12-002661
Filing Date
2012-08-08
Accepted
2012-08-08 16:01:43
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q actc_10q-063012.htm 10-Q 508540
2 CERTIFICATION actc_10q-ex3101.htm EX-31.1 7446
3 CERTIFICATION actc_10q-ex3201.htm EX-31.2 3261
  Complete submission text file 0001019687-12-002661.txt   5468605

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE actc-20120630.xml EX-101.INS 620679
5 XBRL SCHEMA FILE actc-20120630.xsd EX-101.SCH 77040
6 XBRL CALCULATION FILE actc-20120630_cal.xml EX-101.CAL 55100
7 XBRL DEFINITION FILE actc-20120630_def.xml EX-101.DEF 251490
8 XBRL LABEL FILE actc-20120630_lab.xml EX-101.LAB 444678
9 XBRL PRESENTATION FILE actc-20120630_pre.xml EX-101.PRE 353593
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
ADVANCED CELL TECHNOLOGY, INC. (Filer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50295 | Film No.: 121016881
SIC: 2834 Pharmaceutical Preparations